medigraphic.com
ISSN 0016-3813 (Impreso)

2016, Número S1

<< Anterior Siguiente >>

Gac Med Mex 2016; 152 (S1)


Enfermedades gastrointestinales y hepáticas

Moctezuma-Velázquez C, Aguirre-Valadez J

Idioma: Español
Referencias bibliográficas: 87
Paginas: 74-83
Archivo PDF: 104.66 Kb.


RESUMEN

La dieta es considerada un factor importante como desencadenante de síntomas gastrointestinales cuya fisiopatología incluye desde reacciones inflamatorias (con manifestaciones claramente medibles) hasta trastornos funcionales (en los que no se ha podido demostrar o medir efecto orgánico alguno). Incluso la prevalencia de la percepción de la intolerancia a ciertos alimentos puede ir del 20-25% (en población general) hasta un 50-70% en enfermedades como el síndrome de intestino irritable, y se observa particularmente después del consumo de leche y lácteos, alimentos frecuentemente considerados responsables de estas alteraciones gastrointestinales, razón por las que se limita su ingestión. Sin embargo, esta conducta reduce las fuentes de calcio dietético y consecuentemente se favorece el riesgo de descalcificación ósea en la edad adulta. La verdadera intolerancia a los lácteos (deficiencia de lactasa en intestino) explica en gran medida las alteraciones secundarias a su consumo, pero la frecuencia de dicha alteración en las diversas enfermedades intestinales no ha sido establecida. En esta revisión se abordan las enfermedades gastrointestinales más frecuentes y la evidencia que existe respecto al consumo de leche o lácteos, la alteración y la sintomatología asociada con su consumo.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308-28.

  2. Boettcher E, Crowe SE. Dietary proteins and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:728-36.

  3. Caseli M, Zuliani G, Cassol F, et al. Test-based exclusion diets in gastro- esophageal reflux disease patients: a randomized pilot controlled trial. World J Gastroenterol. 2014;20:17190-5.

  4. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence based approach. Arch Intern Med. 2006;166:965-71.

  5. Furuta GT, Katzka DA. Eosinophilic esophagitis. N Eng J Med. 2015;373:1640-8.

  6. Arias A, González-Cervera J, Tenias JM, Lucendo AJ. Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 2014;146:1639-48.

  7. Philpott H, Nandrukar S, Royce G, Thien F, Gibson PR. Allergy tests do not predict food triggers in adult patients with eosinophilic esophagitis. A comprehensive prospective study using five modalities. Aliment Pharmacol Ther [journal on the internet]. 2016 Jun 01 [cited 2016 Jun30]. doi: 10.1111/apt.13676. [Epub ahead of print].

  8. Dellon ES, Gonsalvez N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. ACG Clinical Guideline: Evidence based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis. Am J Gastroenterol. 2013;108:679-92.

  9. Hata Y, Kita T, Murakami M. Bovine milk inhibits both adhesión of Helicobacter pylori to sulfatide and Helicobacter pylori-induced vacuolation of vero cells. Dig Dis Sci. 1999;44:1696-702.

  10. Hirmo S, Kelm S, Iwersen M, et al. Inhibition of Helicobacter pylori sialic acid specific haemagglutination by human gastrointestinal mucins and milk glycoproteins. FEMS Immunology and Medical Microbiology. 1998;20:275-81.

  11. Akedo I, Tatsuta M, Narahara H, et al. Prevention of bovine milk against Helicobacter pylori associated atrophic gastritis through its adherence inhibition. Hepatogastroenterology. 2004;51:277-81.

  12. Sachdeva A, Rawat S, Nagpal J. Efficacy of fermented milk and whey proteins in Helicobacter pylori erradication: a review. World J Gastroenterol. 2014;20:724-37.

  13. Kumar N, Kumar A, Broor SL, Vij JC, Anand BS. Effect of milk on patients with duodenal ulcers. Br Med J. 1986;293:666.

  14. Marotta RB, Floch MH. Diet and nutrition in ulcer disease. Med Clin North Am. 1991;75:967-79.

  15. Vomero ND, Colpo E. Nutritional care in peptic ulcer. Arq Bras Cir Dig. 2014;27:298-302.

  16. Kato I, Nomura AM, Stemmermann GN, Chyou PH. A prospective study of gastric and duodenal ulcer and its relation to smoking, alcohol or diet. Am J Epidemiol. 1992;135:521-30.

  17. Sanka K, Munjulury VS, Mohd AB, Diwan PV. Enhacement of solubility, dissolution release profile and reduction in ulcerogenity of piroxicam by inclusion complex with skimmed milk. Drug Deliv. 2014;21:560-70.

  18. Rosaneli CF, Bighetti AE, Antonio MA, Carvalho JE, Sgarbieri VC. Protective effect of bovine milk whey protein concéntrate on the ulcerative lesions caused by subcutaneous administration of indomethacin. J Med Food. 2004;7:309-14.

  19. Koo MW. The effects of milk and calcium on ethanol induced gastric mucosal damage. Pharmacol Res. 1994;29:217-24.

  20. Matsumoto H, Shimokawa Y, Ushida Y, Toida T, Hayasawa H. New biological function of bovine 􀁟–lactalbumin: protective effect against ethanol and stress induced gastric mucosal injury in rats. Bioschi, Biotechnol, Biochem. 2001;65:1104-11.

  21. Malfertheiner P, Megraud F, O´Morain C, et al. Management of Helicobacter pylori infection – the Mastricht IV/Florence Consensus Report. Gut. 2012;61:646-64.

  22. Lanza FL, Chan FKL, Quigley EMM. Guidelines for prevention of NSAID related ulcer complications. Am J Gastroenterol. 2009;104:728-38.

  23. Loyd RA, McClellan DA. Update on the evaluation and management of functional dyspepsia. Am Fam Physician. 2011;83:547-52.

  24. Anthoni SR, Rasinpera HA, Kotamies AJ, et al. Molecularly defined adult type hypolactasia among working age people with reference to milk consumption and gastrointestinal symptoms. World J Gastroenterol. 2007;13:1230-35.

  25. Anthoni S, Savilahti E, Rautelin H, Kolho KL. Milk protein IgG and IgA: the association with milk-induced gastrointestinal symptoms in adults. World J Gastroenterol. 2009;15:4915-18.

  26. Carvalho RV, Lorena SL, Almeida JR, Mesquita MA. Food intolerance, diet composition and eating patterns in functional dyspepsia patients. Dig Dis Sci. 2010;55:60-5.

  27. Kaess H, Kellermann N, Castro A. Food intolerance in duodenal ulcer patients, non ulcer dyspeptic patients and healthy subjects. A prospective study. Klin Wochenschr. 1988;66:208-11.

  28. Plichiewicz AN, Horowitz M, Holtmann GJ, Talley NJ, Feinle-Bisset C. Relationship between symptoms and dietary patterns in patients with functional dyspepsia. Clin Gastroenterol Hepatol. 2009;7:317-22.

  29. Houghton LA, Mangall YF, Dwivedi A, Read NW. Sensitivity to nutrients in patients with non-ulcer dyspepsia. Eur J Gastroenterol Hepatol. 1993;5:109-14.

  30. Pelto L, Impivaara O, Salminen S, Poussa T, Seppanen R, Lilius EM. Milk hypersensitivity in Young adults. Eur J Clin Nutr. 1999;53:620-24.

  31. Shek LP, Bardina L, Castro R, Sampson HA, Beyer K. Humoral and cellular responses to cow milk proteins in patients with milk-induced IgE-mediated and non-IgEmediated disorders. Allergy. 2005;60:912-9.

  32. Lutchman D, Pillay S, Naidoo R, Shangase N, Nayak R, Rughobeer A. Evaluation of buffering capacity of powdered cow´s, goat´s and soy milk and non-prescription antiacids in the treatment of non-ulcer dyspepsia. S Afr Med J. 2006;96:57-61.

  33. Talley NJ, Vakil N. Guidelines for the management of dyspepsia. Am J Gastroenterol. 2005;100:2324-37.

  34. Feinle-Bisset C, Azpiroz F. Dietary and lifestyle factors in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:150-7.

  35. Rubio-Tapia A, Hill ID, Kelly CP, Calderwod AH, Murray JA. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656-76.

  36. Leffler DA, Dennis M, Hyett B. Etiologies and predictor of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007;5:445-50.

  37. Faulkner-Hogg KB, Selby WS, Loblay RH. Dietary analysis in symptomatic patients with celiac disease on a gluten free dieta: the role of trace amounts of gluten and non-gluten food intolerances. Scand J Gastroenterol. 1999;34.784-9.

  38. Ojetti V, Nucera G, Migneco A, Gabrielli M, Lauritano C, Danese S. Digestion. 2005;71:106-10.

  39. Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut. 2014;63:1210-28.

  40. Bai JC, Fried M, Corazza GR, et al. World Gastroenterology Organization global guidelines on celiac disease. J Clin Gastroenterol. 2013;47:121-6.

  41. Conwell DL, Lee LS, Yadav D, et al. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis. Pancreas. 2014;43:1143-62.

  42. Madry E, Krasinska B, Drzymala-Czyz S, et al. Lactose malabsorption is a risk factor for decreased bone mineral density in pancreatic insufficient cystic fibrosis patients. European Journal of Human Genetics. 2012;20: 1092-95.

  43. Singh N, Joshi YK, Saraya A, Tandon RK. Nutritional profile of patients with chronic pancreatitis. Asia Pacific J Clin Nutr. 1999;8:19-23.

  44. Drewes AM. Nutrition in chronic pancreatitis. World J Gastroenterol. 2013;19:7267-75.

  45. Duggan SN, Smyth ND, Murphy A, Macnaughton D, O´Keefe SJ, Conlon KC. High prevalence of osteoporosis in patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2014;12:219-28.

  46. Forsmark CE. Management of chronic pancreatitis. Gastroenterology. 2013;144:1282-91.

  47. Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome: A clinical review. JAMA. 2015;313:949-58.

  48. Carmona-Sánchez R, Icaza-Chávez ME, Bielsa-Fernández MV, et al. Consenso mexicano sobre intestino irritable. Rev Gastroenterol Mex. 2016;81:149-67.

  49. Sirmén M. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup? Gut. 2014;63:1685-86.

  50. Mayer EA, Labus JS, Tillisch K, Cole SW, Baldi P. Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol. 2015;12:592-605.

  51. Monsbakken Kw, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome etiology, prevalence and consequences. Eur J Clin Nutr. 2006;60:667-72.

  52. Yang J, Fox M, Cong Y, et al. Lactose intolerance in irritable bowel syndrome patients with diarrhea: The roles of anxiety, activation of the innate mucosal system and visceral sensitivity. Aliment Pharmacol Ther. 2014;39:302-11.

  53. Halmos EM, Power VA, Shepherd SJ, Gibson PR, Muir JG. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterol. 2014;146:67-75.

  54. Böhn L, Störsrud S, Liljebo T, Collin L, Linfors P, Törnblom H, Simrén M. Diet low FODMAPs reduces symptoms of irritable bwel syndrome as well a traditional dietary advice: a randomized controlled trial. Gastroenterol. 2015;149:1399-407.

  55. Keetarut K, Kiparissi F, Mc Cartney S, Murray C. Dietary intervention using the low FODMAP diet versus the «milk, egg, wheat and soya free» diet for the treatment of functional gut disorders a single centre experience. JPGN. 2015;61:516 (VII European Gastrointestinal Pediatric Motility Meeting, October 1-3,2015, Sorrento, Italy).

  56. Academy of Nutrition and Dietetics Care Manual. Irritable Bowel Syndrome. Nutrition Prescription. http://www.nutritioncaremanual.org/content_ id=82590. Accesed July 30,2012.

  57. McKenzie YA, Bowyer RK, Leach H, et al. British Dietetic Association systematic review and evidence based practice guidelines for the dietary management of irritable bowel syndrome in adults (2016 update). J Hum Nutr Diet. 2016 Jun 8 [Epub ahead of print].

  58. Ford A, Moayyedi P, Lacy BE, et al. American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiophatic Constipation. Am J Gastroenterol. 2014;109:S2-S26.

  59. Schuppan D, Adhal NH. Liver cirrhosis. Lancet. 2008;371:838-51.

  60. Thalheimer U, De Iorio F, Capra F, et al. Altered intestinal function precedes the appearance of bacterial DNA in serum and ascites in patients with cirrhosis: a pilot study. Eur J Gastroenterol Hepatol. 2010;22:1228-34.

  61. Montano-Loza AJ, Meza-Junco J, Prado CM, et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol. 2012;10:166-73.

  62. Merli M, Giusto M, Lucidi C, et al. Muscle depletion increases the risk of overt and minimal hepatic encephalopathy:results of prospective Study. Metab Brain Dis. 2013;28:281-4.

  63. Merli M, Iebba V, Giusto M. What is new about diet in hepatic encephalopathy. Metab Brain Dis. 2015 Sep 29 [Epub ahead of print].

  64. Tsien C, Davuluri G, Singh D, et al. Metabolic and molecular responses to leucine-enriched branched chain amino acid supplementation in the skeletal muscle of alcoholic cirrhosis. Hepatology. 2015;61:2018-29.

  65. Zina EM, Yarasheski KE. Exercise treatment to counteract protein wasting of chronic disases. Curr Opin Clin Nutr Metab Care. 2003;6:87-93.

  66. Román E, Torrades MT, Nadal MJ, et al. Randomized pilot study: effects of an exercise programme and leucine supplementation in patients with cirrhosis. Dig Dis Sci. 2014;59:1966-75.

  67. Gluud LL, Dam G, Borre M, et al. Oral branched chain amino acids have benefical effect on manifestations of hepatic encephalopathy in a systematic review with metaanalyses of randomized controlled trials. J Nutr. 2013;143:1263-8.

  68. Bajaj JS, Saeian K, Christensen KM, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008; 103:1707-15.

  69. Zivkovic AM, Barile D. Bovine milk as a source of functional oligosaccharides for improving human health. Adv Nutr. 2011;3:284-9.

  70. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by AASLD and EASL. 2014.

  71. Loftus EV: Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504-17.

  72. Cohen AB, Lee D, Long MD, et al. Dietary patterns and self reported associations of diet with symptoms of inflammatory bowel disease. Dig Dis Sci. 2013;58:1322-8.

  73. Magee EA, Edmond LM, Tasker SM, Kong SC, Curno R, Cumming JH. Associations between diet and disease activity in ulcerative colitis patients using a novel method for data analysis. Nut J. 2005;4:7.

  74. Jowett SL, Seal CJ, Pearce MS, et al. Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study. Gut. 2004;53:1479-84.

  75. Pitcher MCL, Cummings JH. Hydrogen sulphide: a bacterial toxin in ulcerative colitis? Gut. 1996:39:1-4.

  76. Anderson AFR. Ulcerative colitis- an allergic phenomenon. Am J Dig Dis. 1942;9:91-8.

  77. Rowe AH. Chronic ulcerative colitis: allergy in its aetiology. Ann Intern Med.1942;17:83-100.

  78. Truelove SC. Ulcerative colitis provoked by milk. BMJ. 1961;5220: 154-60.

  79. Chatterton DE, Nguyen DN, Bering SB, Sangild PT. Anti inflammatory mechanism of bioactive milk proteins in the intestine of newborns. Int J Biochem Cell Biol. 2013;45:1730-47.

  80. Mishkin B, Yalovsky M, Mishkin S. Increasd prevalence of lactose malabsortion in Crohn´s disease patients at low risk for lactose malabsorption based on ethnic origin. Am J Gastroenterol.1997;92:1148-53.

  81. Eadala P, Matthews SB, Waud JP, Green JT, Cambell AK. Association of lactose sensitivity with inflammatory bowel disease –demonstrated by analysis of genetic polymorphism, breath gases and symptoms. Aliment Pharmacol Ther. 2011;34:735-46.

  82. von Tirpitz C, Khon C, Steinkamp M, et al. Lactose intolerance in active Crohn´s disease: clinical value of duodenal lactase analysis. J Clin Gastroenterol. 2002;34:49-53.

  83. Bueno Hernández N, Núñez Aldana M, Ascaño-Gutierrez Ilse, Yamamoto Furusho JK. Evaluation of diet pattern related to the symptoms of Mexican patients with ulcerative colitis (UC): through the validity of questionnaire. Nutr J. 2015;14:25.

  84. Smith PA. Nutritional therapy for active Crohn’s disease. World J Gastroenterol. 2008;14:4420-3.

  85. Lochs H, Allison SP, Meier R, Pirlich M, Kondrup J, Schneider S, van den Berghe G, Pichard C. Introductory to the ESPEN Guidelines on Enteral Nutrition: Terminology, definitions and general topics. Clin Nutr. 2006;25:180-6.

  86. Gibson PR, Shepherd SJ. Personal view: food for thought--western lifestyle and susceptibility to Crohn’s disease. The FODMAP hypothesis. Aliment Pharmacol Ther. 2005;21:1399-409.

  87. Shah ND, Parian AM, Mullin GE, Limketkai BN. Oral diets and nutrition support for inflammatory bowel disease: what is the evidence? Nutr Clin Pract. 2015;30:462-73.




2020     |     www.medigraphic.com